Brian Mueller
About Brian Mueller
Inozyme Pharma’s latest and historical proxy statements do not list Brian Mueller as a director; he is not included among nominees, continuing directors, or beneficial owners as of April 28, 2025 . Accordingly, INZY has not disclosed background, age, tenure, education, or credentials for a director named Brian Mueller .
Past Roles
No INZY disclosure exists for Brian Mueller’s past roles because he is not listed as a director or officer of Inozyme Pharma .
External Roles
No INZY disclosure exists for Brian Mueller’s external directorships or roles because he is not listed as a director or officer of Inozyme Pharma .
Board Governance
- Board composition and classification: INZY’s board has nine members divided into three classes with staggered three‑year terms; Class II nominees at the 2025 meeting were Sarah Bhagat, Reinaldo Diaz, and Erik Harris. Brian Mueller does not appear on the board roster .
- Independence: As of April 2025, all directors except CEO Douglas Treco and former CEO Axel Bolte were independent under Nasdaq rules; Brian Mueller is not referenced .
- Leadership: CEO Douglas Treco serves as Chairman; Reinaldo Diaz is Lead Independent Director with defined responsibilities (executive sessions, agenda setting, shareholder communications) since April 1, 2023 .
- Committees and chairs:
- Audit Committee: Lynne Sullivan (Chair), Sarah Bhagat, Martin Edwards .
- Compensation Committee: Reinaldo Diaz (Chair), Robert Hopfner, Edward Mathers .
- Nominating & Corporate Governance: Martin Edwards (Chair), Edward Mathers .
- Research & Development: Martin Edwards (Chair), Axel Bolte, Douglas Treco .
Brian Mueller holds no committee assignments at INZY because he is not on the board .
- Attendance: The full board met six times in 2024; all directors except Robert Hopfner attended at least 75% of meetings (Hopfner 67%). No attendance record exists for Brian Mueller .
Fixed Compensation
INZY’s director compensation program (applies to non‑employee directors; Brian Mueller is not listed among recipients):
| Component | Annual Amount (USD) |
|---|---|
| Board member cash retainer | $40,000 |
| Board chair incremental retainer | $30,000 |
| Lead Independent Director | $60,000 |
| Audit Committee member | $7,500 |
| Audit Committee chair incremental | $7,500 |
| Compensation Committee member | $5,000 |
| Compensation Committee chair incremental | $5,000 |
| Nominating & Governance member | $4,000 |
| Nominating & Governance chair incremental | $4,000 |
| R&D Committee member | $4,000 |
| R&D Committee chair incremental | $4,000 |
Non‑employee director equity awards (standard program):
- Initial Option: 56,000 shares; monthly vesting over 3 years; change‑in‑control full exercisability .
- Annual Option: 28,000 shares; vests fully at first anniversary or immediately prior to next annual meeting .
2024 actual director compensation shows recipients; Brian Mueller is not among them:
| Director | Cash Fees (USD) | Option Awards (USD) | Total (USD) |
|---|---|---|---|
| Sarah Bhagat | 48,766 | 123,200 | 171,966 |
| Axel Bolte | 40,893 | 123,200 | 164,093 |
| Reinaldo Diaz | 68,125 | 123,200 | 191,325 |
| Martin Edwards | 62,250 | 123,200 | 185,450 |
| Erik Harris | 9,783 | 272,503 | 282,286 |
| Robert Hopfner | 43,750 | 123,200 | 166,950 |
| Edward Mathers | 47,750 | 123,200 | 170,950 |
| Lynne Sullivan | 53,750 | 123,200 | 176,950 |
As of 12/31/2024, outstanding director option counts are disclosed for these directors; none for Brian Mueller .
Performance Compensation
INZY does not disclose performance metrics tied to non‑employee director pay; director equity awards are time‑vested and not subject to TSR/financial targets .
Other Directorships & Interlocks
No INZY disclosure lists Brian Mueller as an INZY director or notes any interlocks involving him. Director affiliations and principal holders are disclosed; Brian Mueller is absent from these sections .
Expertise & Qualifications
No INZY biography exists for Brian Mueller because he is not on the board .
Equity Ownership
Beneficial ownership tables (as of April 28, 2025) list directors, officers, and 5% holders; Brian Mueller is not included and thus has no reported INZY share ownership or options at INZY .
Governance Assessment
- Identity mismatch is a material diligence red flag: INZY does not disclose Brian Mueller as a director. Investors should verify the intended individual and correct company linkage before drawing governance conclusions .
- INZY’s governance framework features a Lead Independent Director, majority independence, defined committee structures, a clawback policy (Dodd‑Frank) for executive compensation, and anti‑hedging/anti‑pledging policies—all supportive of investor alignment. These controls do not pertain to Brian Mueller at INZY given he is not a director .
- Attendance: Overall board attendance in 2024 was strong except for one director (Hopfner at 67%). No attendance is applicable for Brian Mueller at INZY .
RED FLAGS
- Requested subject not found on INZY’s board in 2024–2025 proxies; proceeding under an incorrect identity would undermine governance analysis reliability .
- No related‑party transactions, compensation, or ownership disclosures exist for Brian Mueller at INZY because he is not a director/officer .
If you intended a different person or company association (e.g., an individual named Brian Mueller at another issuer), please specify so we can extract the proper governance intelligence.